Pfizer Historical Financial Ratios
| PFE Stock | USD 25.65 0.52 2.07% |
Pfizer is promptly reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 16.61, Free Cash Flow Yield of 0.0446, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.43 will help investors to properly organize and evaluate Pfizer Inc financial condition quickly.
Pfizer |
About Pfizer Financial Ratios Analysis
Pfizer IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pfizer investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pfizer financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pfizer history.
Pfizer Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Pfizer Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pfizer sales, a figure that is much harder to manipulate than other Pfizer Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Pfizer Inc dividend as a percentage of Pfizer stock price. Pfizer Inc dividend yield is a measure of Pfizer stock productivity, which can be interpreted as interest rate earned on an Pfizer investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Payout Ratio
Payout Ratio is the proportion of Pfizer Inc earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of Pfizer Inc dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating Pfizer Inc is paying out more in dividends than it makes in net income.Most ratios from Pfizer's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. At present, Pfizer's Dividend Yield is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 79.81, whereas Operating Cash Flow Per Share is forecasted to decline to 1.43.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0264 | 0.0313 | 0.0569 | 0.0598 | Price To Sales Ratio | 4.07 | 2.86 | 2.78 | 4.61 |
Pfizer fundamentals Correlations
Click cells to compare fundamentals
Pfizer Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pfizer fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 4.0 | 4.88 | 4.07 | 2.86 | 2.78 | 4.61 | |
| Ptb Ratio | 3.28 | 3.23 | 4.28 | 3.0 | 1.83 | 1.73 | |
| Days Sales Outstanding | 47.76 | 68.92 | 51.54 | 39.84 | 69.74 | 79.81 | |
| Book Value Per Share | 11.39 | 11.43 | 13.83 | 17.1 | 15.82 | 16.61 | |
| Free Cash Flow Yield | 0.0483 | 0.0568 | 0.0903 | 0.0906 | 0.0295 | 0.0446 | |
| Stock Based Compensation To Revenue | 0.0139 | 0.018 | 0.0145 | 0.008691 | 0.008975 | 0.00928 | |
| Capex To Depreciation | 0.43 | 0.58 | 0.52 | 0.64 | 0.62 | 1.23 | |
| Pb Ratio | 3.28 | 3.23 | 4.28 | 3.0 | 1.83 | 1.73 | |
| Ev To Sales | 5.28 | 4.98 | 5.75 | 3.21 | 4.01 | 3.66 | |
| Free Cash Flow Per Share | 1.79 | 2.09 | 5.33 | 4.64 | 0.85 | 1.21 | |
| Inventory Turnover | 1.23 | 1.08 | 3.4 | 3.82 | 2.91 | 3.06 | |
| Net Income Per Share | 2.92 | 1.26 | 3.92 | 5.59 | 0.38 | 0.36 | |
| Days Of Inventory On Hand | 295.85 | 337.87 | 107.28 | 95.45 | 125.27 | 119.01 | |
| Payables Turnover | 2.63 | 2.03 | 5.53 | 5.04 | 4.42 | 2.64 | |
| Capex To Revenue | 0.0501 | 0.0666 | 0.0334 | 0.0323 | 0.0668 | 0.0605 | |
| Cash Per Share | 1.77 | 2.2 | 5.55 | 4.05 | 2.25 | 1.67 | |
| Pocfratio | 16.43 | 14.2 | 10.15 | 9.82 | 18.67 | 22.12 | |
| Interest Coverage | 9.62 | 7.34 | 19.24 | 32.33 | 1.52 | 1.44 | |
| Payout Ratio | 0.49 | 1.2 | 0.4 | 0.29 | 4.36 | 4.58 | |
| Capex To Operating Cash Flow | 0.21 | 0.19 | 0.0832 | 0.11 | 0.45 | 0.31 | |
| Pfcf Ratio | 20.7 | 17.61 | 11.07 | 11.04 | 33.9 | 41.5 | |
| Days Payables Outstanding | 138.84 | 179.85 | 66.06 | 72.36 | 82.5 | 138.18 | |
| Ev To Operating Cash Flow | 20.47 | 16.73 | 11.23 | 11.0 | 26.97 | 24.0 | |
| Pe Ratio | 12.71 | 29.13 | 15.05 | 9.16 | 76.67 | 80.5 | |
| Return On Tangible Assets | 0.22 | 0.0922 | 0.21 | 0.31 | 0.0226 | 0.0215 | |
| Ev To Free Cash Flow | 25.78 | 20.75 | 12.25 | 12.36 | 48.96 | 44.36 | |
| Earnings Yield | 0.0459 | 0.0787 | 0.0343 | 0.0665 | 0.013 | 0.0124 | |
| Net Debt To E B I T D A | 2.7 | 2.77 | 1.14 | 0.84 | 7.55 | 7.93 | |
| Tangible Book Value Per Share | (5.49) | (2.62) | 0.56 | 0.21 | (7.69) | (7.31) | |
| Receivables Turnover | 7.64 | 5.3 | 7.08 | 9.16 | 5.23 | 4.22 | |
| Graham Number | 27.3 | 17.99 | 34.89 | 46.34 | 11.54 | 10.5 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Dividend Share 1.67 | Earnings Share 0.75 | Revenue Per Share 10.493 | Quarterly Revenue Growth 0.312 |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.